Did you know?
ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Free Newsletter
Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!
Free Report
Deals and Financings-BGI Genomics completed a $81 million...
Eli Lilly and Company will not attempt a large-scale...
Eli Lilly has taken another step in transforming itself...
Sinopharm Group could win the $3 billion auction for...
Charles River Laboratories and WuXi PharmaTech said they...
For the first time in its 29 years, the J.P. Morgan...
Charles River Labs intends to sell its Shanghai...
Lilly remains worried about IP theft in China, even...
As the end of the year approaches, so does the annual...
Jiangsu Hengrui Medicine has entered a strategic...
ChinaBio® News
Greg Scott Interviewed at BIO-Europe Spring
How to bring your China assets to China in 8 minutes
"Mr. Bio in China."
Mendelspod Interview
Multinational pharma held to a higher standard in China
